EIQ Stock Overview
Provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Echo IQ Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.26 |
| 52 Week High | AU$0.32 |
| 52 Week Low | AU$0.10 |
| Beta | 0.97 |
| 11 Month Change | 13.33% |
| 3 Month Change | 70.00% |
| 1 Year Change | 59.38% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -72.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| EIQ | AU Software | AU Market | |
|---|---|---|---|
| 7D | 9.7% | -4.1% | -0.3% |
| 1Y | 59.4% | 81.4% | 18.4% |
Return vs Industry: EIQ underperformed the Australian Software industry which returned 81.4% over the past year.
Return vs Market: EIQ exceeded the Australian Market which returned 18.4% over the past year.
Price Volatility
| EIQ volatility | |
|---|---|
| EIQ Average Weekly Movement | 15.5% |
| Software Industry Average Movement | 9.4% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: EIQ's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: EIQ's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Andrew Grover | www.echoiq.ai |
Echo IQ Limited provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. It operates through Houston We Have Software and Echo IQ segments. The company offers EchoSolv, an AI software for identification of aortic stenosis heart condition to physicians and healthcare facilities.
Echo IQ Limited Fundamentals Summary
| EIQ fundamental statistics | |
|---|---|
| Market cap | AU$147.13m |
| Earnings (TTM) | -AU$5.41m |
| Revenue (TTM) | AU$44.50k |
3,306x
P/S Ratio-27.2x
P/E RatioIs EIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EIQ income statement (TTM) | |
|---|---|
| Revenue | AU$44.50k |
| Cost of Revenue | AU$2.92m |
| Gross Profit | -AU$2.88m |
| Other Expenses | AU$2.53m |
| Earnings | -AU$5.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0092 |
| Gross Margin | -6,471.45% |
| Net Profit Margin | -12,155.38% |
| Debt/Equity Ratio | 0% |
How did EIQ perform over the long term?
See historical performance and comparison